These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8953584)

  • 1. Lymph node removal may provide prognostic information for melanoma patients.
    Oncology (Williston Park); 1996 Nov; 10(11):1637-8. PubMed ID: 8953584
    [No Abstract]   [Full Text] [Related]  

  • 2. [For the benefit of the patient: the sentinel node excision].
    Satzger I; Klein M; Löser C; Möhrle M; Reske S; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):922-6. PubMed ID: 22026360
    [No Abstract]   [Full Text] [Related]  

  • 3. Sentinel node biopsy: facts to clear the alleged clouds.
    Morton DL; Elashoff R
    Arch Dermatol; 2008 May; 144(5):685-6; author reply 687. PubMed ID: 18490604
    [No Abstract]   [Full Text] [Related]  

  • 4. The persistent anchor of lymph node removal in patients with melanoma.
    Byrd DR
    Cancer; 2010 Mar; 116(5):1150-2. PubMed ID: 20066718
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanoma patients with melanoma micrometastases in sentinel node that refused completion lymphadenectomy.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Farfaglia R; Pizzocaro C; Ungari M; Calzavara-Pinton PG
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1008-9. PubMed ID: 18201174
    [No Abstract]   [Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of the lymph nodes in patients with malignant melanoma.
    Cochran AJ; Robert ME; Wen DR
    Pathology (Phila); 1994; 2(2):385-400. PubMed ID: 9420909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time for comprehensive reporting of MSLT-I.
    Thomas JM
    Lancet Oncol; 2006 Jan; 7(1):9-11; author reply 11-2. PubMed ID: 16389178
    [No Abstract]   [Full Text] [Related]  

  • 9. Sentinel node and survival in melanoma.
    Russell-Jones R
    Br J Dermatol; 2005 Dec; 153(6):1093-5. PubMed ID: 16307641
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases.
    Mocellin S; Pasquali S; Rossi CR; Nitti D
    Surgery; 2011 Jul; 150(1):83-90. PubMed ID: 21683860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated tumor cells and long-term prognosis of patients with melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Eggermont AM
    Ann Surg Oncol; 2008 May; 15(5):1547-8. PubMed ID: 18197454
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
    Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
    J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma?
    Satzger I; Meier A; Alter M; Kapp A; Gutzmer R
    J Clin Oncol; 2011 Apr; 29(11):e315; author reply e316-7. PubMed ID: 21383303
    [No Abstract]   [Full Text] [Related]  

  • 14. Sentinel-node biopsy in melanoma.
    Kanzler MH; Levitt L; Lin A
    N Engl J Med; 2007 Jan; 356(4):419; author reply 419-21. PubMed ID: 17256191
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of malignant melanoma, axillary lymph node metastasis proved by fine needle aspiration biopsy cytology].
    Shinozaki N; Hashimoto K; Yamaguchi A; Hukunaga M; Hosoya T; Uchida K; Ishikawa M; Sakurai K
    Gan No Rinsho; 1987 Apr; 33(4):438-41. PubMed ID: 3573315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completion lymphadenectomy for melanoma patients with a positive sentinel node biopsy remains standard of care.
    Henderson MA
    Ann Surg Oncol; 2006 Jun; 13(6):761-3. PubMed ID: 16614873
    [No Abstract]   [Full Text] [Related]  

  • 17. Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma.
    Thomas JM
    J Am Acad Dermatol; 2009 Dec; 61(6):1079. PubMed ID: 19925932
    [No Abstract]   [Full Text] [Related]  

  • 18. Too much surgery and too little benefit? Sentinel node biopsy for melanoma as it currently stands.
    McGregor JM
    Br J Dermatol; 2013 Aug; 169(2):233-5. PubMed ID: 23941245
    [No Abstract]   [Full Text] [Related]  

  • 19. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    Miranda EP
    J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
    Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.